Research Frontiers 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Research Frontiers reported 3rd quarter 2026 net income of approximately $77,000, compared with approximately $359,000 in the 3rd quarter of 2025; the year-earlier quarter included government contract royalty revenue that did not recur.
- The net loss for the quarter was approximately $510,000, compared with just under $300,000 a year earlier.
- At September 30th, Research Frontiers had approximately $645,000 in cash and cash equivalents and approximately $538,000 in working capital.
- Gausi’s court-approved Israeli debt settlement became effective in September, its October financing closed, and payments have begun to support restarting SPD emulsion manufacturing in Israel and SPD film manufacturing in Germany.
- Gausi reported that its Israeli settlement addresses approximately $61 million of pre-petition liabilities; its October financing was led by CEO Eyal Pezo and other investors.
- Research Frontiers said the supply disruption constrained SPD material production, customer deliveries, and royalties, while its automotive programs and relationships remained intact.
- Four automakers—Mercedes, Ferrari, Cadillac, and McLaren—have selected SPD, and the company cited two production business jets using SPD smart glass, a newly unveiled light jet whose manufacturer prefers SPD, and a new aircraft development project started with a North American manufacturer.
- Research Frontiers said its architectural retrofit licensee has established substantial manufacturing facilities and is engaging on existing and prospective projects.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good afternoon, and welcome to Research Frontiers' investor conference call to discuss the third quarter of 2026 results of operations and recent developments. The company will be answering many of the questions that were emailed to it prior to this conference call in their presentation. In some cases, the company has responded directly to email questions prior to this call or will do so afterwards. There will be a live question-and-answer session after the company's presentation. Some statements today may contain forward-looking information identified by words such as expect, anticipate, and forecast. These reflect current beliefs, and actual results may differ materially from those expressed due to various risk factors, including those detailed in our SEC filings. Research Frontiers assumes no obligation to update or revise these statements. The call is being recorded and will be available for replay on Research Frontiers' website at smartglass.com for the next 90 days.
I would now like to turn the conference over to Joe Harary, President and Chief Executive Officer of Research Frontiers.
Please go ahead, sir. Thank you, Paul, and good afternoon, everyone, and welcome to Research Frontiers' third quarter 2026 investor conference call.
I appreciate you taking the time to join us, and I particularly appreciate the thoughtful questions many of you sent by email in advance. in August, much of our discussion concerned the disruption at Gauzy and the alternatives available to restore SPD film supply. Today, I want to have a different conversation because we have concrete progress to report. Gauzy's court-approved Israeli settlement became effective in September. Additional financings closed in October, and as Gauzy announced in October, payments have begun flowing to support the restart of SPD emulsion manufacturing in Israel and SPD film manufacturing in Germany. These are important steps that move us along in resuming production and dependable deliveries.
To appreciate the significance of these developments, let's go back to our November 6, 2025 investor call, just one year ago. We were reporting increased automotive royalties and growing royalties overall. Research Frontiers had more than $1.1 million in cash, no debt, and an expanding pipeline in automotive, aerospace, architecture, and other markets. We were not discussing a technology in search of a market. We were discussing a technology already selected by leading automakers, proven in aircraft, and attracting interest in new applications. Our focus was on converting development programs into production and expanding royalties. That same week, our architectural retrofit system debuted at GlassBuild in Orlando to strong interest from architects, building owners, and glazing professionals, and we were preparing for major automotive glazing discussions in Detroit.
I also was asked to chair the conference and deliver the keynote address at the Detroit Automotive Glazing Summit that month as well. There was genuine commercial momentum. Then, on November 13, 2025, just seven days after our conference call, and just as Gauzy was preparing to give their third quarter 2025 investor conference call, Vision Systems was involuntarily placed into a court-supervised rehabilitation proceeding in France, and the disruption that followed across the Gauzy group struck a critical link in our SPD manufacturing supply chain. That triggered a technical event of default on Gauzy's credit line, which in turn prevented the refinancing to a lower interest debt facility and choked off Gauzy's liquidity and capital resources. In the space of a week, our conversation changed from how quickly we could build on our momentum to how we could preserve the manufacturing capacity needed to serve our customers.
Gauzy hit a brick wall, but it was a financing and manufacturing brick wall, not a rejection of SPD technology by the marketplace. The engineering qualifications, customer relationships, and opportunities that took years to develop did not vanish. What was interrupted was our ability to supply them. That is why restoring production matters so much today. That was then, and now the recent settlement, debt settlement, financing, and initial payments give us a critical path to rebuild the supply channel and fill existing customer orders and generate new business. You will later on hear that we are in fact doing that, and we will be talking about several new projects for SPD in different markets. I will cover Gauzy, our financial position, progress in our principal markets, and priorities ahead, and then we will open the line for your questions. What changed at Gauzy? The financial projections and proceedings involving Gauzy and its subsidiaries sharply constrained SPD material production, customer deliveries, and our royalties during the past year.
The debt settlement and financing are now completed milestones rather than hoped-for outcomes. Gauzy has reported that its Israeli settlement addresses approximately $61 million of pre-petition liabilities. Its October financing was led by CEO Eyal Peso and other investors. Management's willingness to invest its own money demonstrates tangibly an encouraging sign of commitments. Payments have begun to support restarting the two linked stages of our supply chain, SPD emulsion production in Israel and SPD film manufacturing in Germany. The emulsion is the critical light control material. It must then be converted into high-quality film that our licensees and their customers incorporate into finished products. Both stages are essential, and neither alone can supply our licensees.
Our operational priorities are clear and practical ones: bring people and equipment back into production operation, meet quality specifications and customer demand, establish consistent output, fill back orders, and restore dependable delivery schedules. The proceedings in France involving Gauzy subsidiaries, including matters described in Gauzy's filings, but those are not the same as what affects the German film coating and Israeli emulsion operations. They are part of the larger Gauzy situation and warrant continued attention. Basically, Germany and Israel were liquidity-based, and France was the legal proceedings. We are not going to speculate about the outcome of those proceedings. The French appellate court is expected to rule on two appeals by Gauzy.
Some say it was expected today, although I have not gotten word that the decision was handed down yet. I do not think that means anything other than perhaps they have a different method of distribution in France of legal opinions. The two appeals really focused on, one, whether Gauzy should be forced to sell their Vision Systems division to a Lyon-based company called Clayens, and whether putting them into an an involuntary rehabilitation proceeding was even proper or called for in the first place. While the outcome of either of these appeals does not impact production of emulsion in Israel or SPD film in Germany, and we are expected to get paid our royalties either way, a success by Gauzy on either of these appeals can bring substantial capital into Gauzy and even allow them to pay off all of their debt worldwide.
We are, of course, rooting for Gauzy to win one or both of these appeals. A successful win on either of them will make Gauzy a substantially stronger manufacturing and marketing partner. We also consider longer-term supply resilience and alternative manufacturing options. Our immediate priority, however, is the most direct route to dependable supply, which is through the existing manufacturing channel with an SPD film from Gauzy that has already been used and validated by customers in all industries. Now let me address our financial results, because they show why restoring production is so important. Fee income in the third quarter was approximately $77,000 compared to approximately $359,000 in the third quarter of 2025. The year-earlier quarter included government contract royalty revenue that did not recur, and the current period also reflects the significant effect of constrained SPD material supply.
The net loss for the quarter was approximately $510,000 compared to just under $300,000 a year earlier. At September 30th, we had approximately $645,000 in cash and cash equivalents and approximately $538,000 in working capital. Our Form 10-Q discusses the importance of collections, operating cash flow, and potential additional financing. Gauzy's $7 million financing was not financing for Research Frontiers. It may, however, help restart production and provide a path towards collecting amounts owed to us by Gauzy-related entities, as well as generating new royalties from sales of SPD products by our licensees and filling the backlog of existing orders. Our licensing model means royalties follow the sale of products incorporating SPD technology. Even after film production restarts, royalties follow only after end product licensees receive and incorporate the film into finished products and sell them to their customers.
We do not expect a restart to produce a material royalty recovery until after the fourth quarter of 2026. At the same time, Research Frontiers does not need to build a factory every day, every time an automaker, aircraft manufacturer, or architectural customer has a program. Our licensees invest in manufacturing, engineering, marketing, and product development, giving us the potential for substantial operating leverage as their production and sales grow without proportional capital expenditures of our own. That is an essential part of our business plan, but the trade-off is that we have dependence on those partners, and this year, we experienced that downside directly. We are focused on restoring supply while evaluating how to strengthen resilience over time. We have continued to control expenditures and work on amounts owed to us.
Some receivables involve parties subject to court-supervised proceedings, namely Gauzy and Vision Systems, and is subject to the timetable set by those court tribunals. We believe that these should all be collected this month or next month. Our recent results reflect the supply disruption, not the full potential of our technology of our markets. We are optimistic that through execution, we will show much stronger royalty results. That is the standard that we are applying to ourself. Let me tell you now about where those royalties will be coming from. In automotives, the advantages of SPD are easy to experience. Drivers and passengers want light when it is desirable and protection from heat and glare when it is not, and SPD makes that adjustment rapidly, precisely, and uniformly. It is the best-performing smart glass in the world. As automakers use ever-larger panoramic glass surfaces, active light control becomes even more useful.
Now consider the significance of our automotive record. Four premier automakers have already selected SPD: Mercedes, Ferrari, Cadillac, and McLaren. Each selection reflects years of engineering, testing, and qualification against demanding standards for optical performance, appearance, durability, and integration into differing and unique procurement processes of four different companies. To our knowledge, no other electronically dimmable glazing technology can point to that breadth of real-world automotive validation. Importantly, our existing automotive programs and relationships have remained intact throughout the Gauzy supply interruption. Vehicle models and production schedules evolve, but the technical credibility, supply relationships, and customer knowledge built across those four automakers endure with Research Frontiers. Our opportunity is to use those qualifications to serve continuing requirements and to compete for follow-on programs within these automakers and establish or expand new or existing development programs at other OEMs once reliable film supply is restored.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
7 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
